David Liu (Jessica Rinaldi/The Boston Globe via Getty Images)
April 5, 2025 06:30 PM EDTUpdated 06:49 PM
People

Q&A: David Liu talks about sci­ence un­der pres­sure, teas­es “dis­ease-ag­nos­tic” gene edit­ing

Ryan Cross

Senior Science Correspondent

Gene edit­ing pi­o­neer David Liu was award­ed one of three Break­through Prizes in Life Sci­ences for his in­ven­tion of base and prime edit­ing. The two …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

Q&A: A con­ver­sa­tion with GLP-1 co-dis­cov­er­er Jens Ju­ul Holst on the fu­ture of in­cretin-based drugs

Trump ad­min­is­tra­tion leaves obe­si­ty cov­er­age ex­pan­sion out of new Medicare rule

Marks was asked to pro­vide non-ex­is­tent vac­cine risk da­ta: WSJ

Se­cre­tive Chi­nese start­up be­gins first-ever clin­i­cal tri­al of cir­cu­lar RNA ther­a­py

Kennedy team de­fends Marks fir­ing, while 20% of staff cuts may be 'mis­takes'

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times